Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/10/1999US5935951 1-acyl-4-aliphatylaminopiperidine compounds
08/10/1999US5935950 Cephalosporin pyridinium derivatives
08/10/1999US5935949 Use of androgen therapy in fibromyalgia and chronic fatigue syndrome
08/10/1999US5935948 Method of treating and preventing gallstones
08/10/1999US5935947 Imidobisphosphoric acids, and use thereof
08/10/1999US5935945 Methods of treating or preventing cardiac arrhythmia
08/10/1999US5935944 Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA)
08/10/1999US5935940 Compositions and methods for modulating growth of a tissue in a mammal
08/10/1999US5935939 A solid state amorphous excipient for gastric antisecretory agent, antiulcer agent
08/10/1999US5935938 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
08/10/1999US5935936 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
08/10/1999US5935935 Adenoviral vectors for treatment of hemophilia
08/10/1999US5935934 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
08/10/1999US5935933 Anticonvulsant derivatives useful in treating neuropathic pain
08/10/1999US5935930 Antithrombotic materials and methods
08/10/1999US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas
08/10/1999US5935860 Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
08/10/1999US5935830 Site-directed mutagenesis by forming triple helix with double-stranded dna and oligonucleotide with electrophilic group, electrophilic group causes modification of dna nucleotide, then replication causes mutation
08/10/1999US5935821 Nucleotide sequence that codes polypeptide anti-idiotype immunoglobulin a ganglioside useful in the suppression of cancer and reduction of recurrence; anticarcinogenic agents
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935803 Methods to identify immunomodulators using cognate interaction of PKC-theta
08/10/1999US5935795 Glial cell line-derived neurotrophic factor antibody
08/10/1999US5935781 Apolipoprotein E polymorphism and treatment of Alzheimer's disease
08/10/1999US5935776 Small molecule inhibition of RNA/ligand binding
08/10/1999US5935636 Cultivating in a nutrient culture medium containing maltose and a microorganism capable of producing a maltose/trehalose conversion enzyme to produce trehalose from maltose but not from sucrose
08/10/1999US5935604 A pulse effect, followed by controlled release and absorption of nicotine to provide a sustained high level of absorbed nicotine
08/10/1999US5935602 Dosage forms of risedronate
08/10/1999US5935601 Acylated peptide as a carrier for oral administration
08/10/1999US5935598 Iontophoretic delivery of cell adhesion inhibitors
08/10/1999US5935591 Method for treatment of equine protozoal myeloencephalitis with thiazolides
08/10/1999US5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin
08/10/1999US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics
08/10/1999US5935564 Use of hydrophobic interaction chromatography to purify polyethylene glycols
08/10/1999US5935559 Silicone composition containing a water-sensitive active agent
08/10/1999US5935555 Pharmaceutical formulations for treating cystic fibrosis
08/10/1999US5934273 Administration of drugs by means of a dry powder inhaler which enhances efficient delivery to the lungs, prevents deposition in mouth and throat
08/10/1999CA2260698A1 Pyrrolidine and piperidine derivatives
08/10/1999CA2201264C Immediate release ph-independent solid dosage form of cisapride
08/10/1999CA2145078C Crystalline penicillin derivative, and its production and use
08/10/1999CA2098593C Treatment method for cancer
08/10/1999CA2093403C Therapeutic agent for parkinson's disease
08/10/1999CA2011144C Nicotinic acid derivatives and pharmaceutical compositions comprising same
08/10/1999CA2006529C N-pyridinyl-9h-carbozol-9-amines, a process for their preparation and their use as medicaments
08/10/1999CA2004695C Phospholipid nucleosides
08/10/1999CA1340695C Antibacterial agents
08/09/1999WO1999039680A1 Antifungal nail lacquer and method using same
08/09/1999CA2260701A1 Method of preparing substituted quinazolin-4-ones
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999039238A1 Methods and apparatus for accelerated orthokeratology
08/05/1999WO1999039045A1 Aqueous compositions comprising complexing agents and uses therof
08/05/1999WO1999038998A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999WO1999038964A2 Promoter regions of the mouse and human telomerase rna component genes
08/05/1999WO1999038963A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999WO1999038877A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
08/05/1999WO1999038876A1 Glycosidation of 4,5-epoxymorphinan-6-ols
08/05/1999WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038869A1 Therapeutic compounds
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038864A1 Oxazole derivatives as serotonin-1a receptor agonists
08/05/1999WO1999038863A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/05/1999WO1999038862A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
08/05/1999WO1999038860A1 Methods for separating a tocotrienol from a tocol-containing mixture and compositions thereof
08/05/1999WO1999038859A1 Methods for separating a tocol from a tocol-containing mixture
08/05/1999WO1999038858A1 Benzo[b]pyran derivatives useful as external agents for the skin
08/05/1999WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
08/05/1999WO1999038846A1 Immunosuppressive agents
08/05/1999WO1999038845A1 Ppar-gamma modulators
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038841A1 Adamantanecarboximidamide derivatives and their use as nmda antagonists
08/05/1999WO1999038829A1 Novel tricyclic compound
08/05/1999WO1999038827A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST
08/05/1999WO1999038821A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
08/05/1999WO1999038546A1 Hydrophilic coating for an intracorporeal medical device
08/05/1999WO1999038545A1 Lubricious hydrophilic coating for an intracorporeal medical device
08/05/1999WO1999038537A1 METHODS FOR TREATING Th1-ASSOCIATED IMMUNE DISORDERS
08/05/1999WO1999038534A1 Neurotrophic factor secretion promoters
08/05/1999WO1999038533A1 Preventives or remedies for vision disorders
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038521A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
08/05/1999WO1999038518A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/05/1999WO1999038516A1 Neurotrophic properties of ipgs and ipg analogues
08/05/1999WO1999038515A1 Optic papillary circulation improving agents
08/05/1999WO1999038514A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999WO1999038513A1 R-lansoprazole compositions and methods
08/05/1999WO1999038512A1 S-lansoprazole compositions and methods
08/05/1999WO1999038511A1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
08/05/1999WO1999038510A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999WO1999038509A1 Isoflavanoid formulations for oral administration
08/05/1999WO1999038508A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
08/05/1999WO1999038507A1 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
08/05/1999WO1999038506A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
08/05/1999WO1999038505A1 Compositions for prevention and treatment of cold and influenza-like symptoms associated with respiratory tract infections
08/05/1999WO1999038504A1 Pharmaceutical uses of optically pure (-)-bupropion
08/05/1999WO1999038503A1 Pharmacological uses of optically pure (+)-bupropion
08/05/1999WO1999038502A1 Pharmaceutical uses of optically pure (+)-bupropion
08/05/1999WO1999038501A2 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999WO1999038500A2 The human calcium-sensing receptor in the detection and treatment of cancer
08/05/1999WO1999038499A2 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
1 ... 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 6480 6481 6482 6483 ... 7860